No Stereoselective First-pass Hepatic Extraction of Propranolol
Overview
Authors
Affiliations
The plasma level: time profile for l-propranolol and total propranolol concentrations were examined in normotensive subjects after intravenous and oral dl-propranolol. l-Propranolol concentrations in plasma accounted for about 60% of total propranolol. This was attributed to lower volume of distribution for the isomer. Mean plasma clearance of 1-propranolol was similarly affected while apparent plasma half-life for the l-isomer and total propranolol were of the same order. Oral bioavailability of 1- and total propranolol averaged 40.7 +/- 8.5% and 42.4 +/- 12.9%. Food and hydralazine increased oral bioavailability of total and l-propranolol by similar magnitudes. We conclude that difference in the kinetics of l- and total propranolol concentrations in plasma are small and probably of no clinical significance. Presystemic clearance of propranolol in man does not appear to be stereospecific.
Bouchard J, Shepherd G, Hoffman R, Gosselin S, Roberts D, Li Y Crit Care. 2021; 25(1):201.
PMID: 34112223 PMC: 8194226. DOI: 10.1186/s13054-021-03585-7.
Levitt D BMC Clin Pharmacol. 2002; 2:5.
PMID: 12182760 PMC: 126244. DOI: 10.1186/1472-6904-2-5.
Albani F, Riva R, Contin M, Baruzzi A Br J Clin Pharmacol. 1984; 18(2):244-6.
PMID: 6487464 PMC: 1463537. DOI: 10.1111/j.1365-2125.1984.tb02462.x.
Prediction of metabolic drug interactions involving beta-adrenoceptor blocking drugs.
Park B Br J Clin Pharmacol. 1984; 17 Suppl 1:3S-10S.
PMID: 6146338 PMC: 1463283. DOI: 10.1111/j.1365-2125.1984.tb02422.x.
Kinetics and metabolism of (+)-, (-)- and (+/-)-bufuralol.
Francis R, East P, Larman J Eur J Clin Pharmacol. 1982; 23(6):529-33.
PMID: 6130953 DOI: 10.1007/BF00637501.